Surgical Stents Market Overview
As per MRFR analysis, the Surgical Stents Market Size was estimated at 5.79 (USD Billion) in 2023.The Surgical Stents Market Industry is expected to grow from 6.07(USD Billion) in 2024 to 10.2 (USD Billion) by 2035. The Surgical Stents Market CAGR (growth rate) is expected to be around 4.82% during the forecast period (2025 - 2035)
Key Surgical Stents Market Trends Highlighted
Advancements in healthcare technology, rising incidence of chronic illnesses, and an aging population are driving many significant trends in the Global Surgical Stents Market. The increase in cardiovascular and orthopaedic operations, which are driving a greater need for stents used in many different treatments, is a major primary market driver. Surgical stents' use and efficacy have also been enhanced by material and design developments, therefore attracting a larger spectrum of patients and healthcare professionals. Innovations like drug-eluting stents and biodegradable ones are becoming more prevalent, improving patient outcomes, and lowering recovery times.
Particularly in minimally invasive surgical procedures, the growth of stent applications is opening more possibilities. Surgical techniques change, opening up more possibilities for stents to be employed in other fields, such as urology and gastrointestinal operations, hence enabling producers to access larger markets. Furthermore, the increasing emphasis on patient-centric healthcare solutions points to a market ready for growth, particularly in areas where access to modern stent technology is lacking.
Recent developments indicate a growing focus on precision medicine and bespoke stent designs fit for particular patient requirements. Stent makers are encouraged to change with the times by putting money into research and development as the worldwide healthcare industry is heading toward a more individualized strategy.
Regulatory bodies all over are likewise strengthening rules on stent quality and safety, hence improving market credibility but also creating difficulties for smaller companies. Driven by both technology developments and shifting healthcare paradigms, the Global Surgical Stents Market is developing quickly overall.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Surgical Stents Market Drivers
Increasing Prevalence of Cardiovascular Diseases
The rising global prevalence of cardiovascular illnesses is a major factor in the Global Surgical Stents Market Industry. The World Health Organization (WHO) estimates that over 32% of all worldwide deaths, roughly 17.9 million people, are caused by cardiovascular illnesses. This concerning number has spurred more use of surgical stents, which are used in operations like angioplasty to enhance blood flow in blocked arteries.
Established companies like the American Heart Association (AHA) are also always raising awareness and supporting research projects. Emphasizing early identification and treatment of cardiac problems, their recommendations push the need for creative stent technology. Moreover, the higher spending on Research & Development by leading medical device manufacturers in reaction to these concerning figures is likely to improve results in cardiovascular treatments and support market expansion in the near future.
Technological Advancements in Stent Design
Rapid technical developments in stent designs are driving the significant expansion of the Global Surgical Stents Market Industry. Innovations like drug-eluting stents and bioresorbable stents have changed the treatment methods of various vascular disorders. The U.S. Food and Drug Administration (FDA) claims that the introduction of these sophisticated stents greatly lowers the likelihood of restenosis and other post-surgical problems.
Leading businesses such as Boston Scientific and Medtronic are spending more in Research and development to improve stent performance, driving the expansion of the surgical stents market. These developments not only enhance patient outcomes but also raise the general acceptability of stent operations worldwide, hence driving market growth.
Growing Geriatric Population
The demographic change toward an elderly world population is another important element propelling the Global Surgical Stents Market Industry. The United Nations estimates that by 2050, almost tripling from 1 billion in 2020, 2 billion individuals will be aged 60 years and older. This age group is largely prone to chronic disorders needing surgical procedures, including cardiovascular diseases and peripheral artery diseases, leading to increased demand for surgical stents.
Organizations like the National Institute on Aging are pushing for improved healthcare solutions for the elderly, emphasizing the need for creative medical devices like stents. The surgical stents market is projected to see significant expansion as the elderly population grows, hence stressing the pressing need for focused healthcare strategies for this group.
Rising Investment in Healthcare Infrastructure
Growing healthcare spending all around is supporting the Global Surgical Stents Market. Nations are giving healthcare infrastructure more money, hence improving access to surgical and diagnostic treatments. Reaching almost 10% of gross domestic product (GDP) in several developed countries, the World Bank shows a significant rise in worldwide health expenditure. Healthcare systems growth means more access to sophisticated medical technology such as surgical stents.
Through government programs, nations like Germany and France have increased their spending on contemporary healthcare facilities and technology. This increase in healthcare infrastructure directly enables the greater use of stents, hence helping the general direction of the industry.
Surgical Stents Market Segment Insights
Surgical Stents Market Product Type Insights
The Global Surgical Stents Market, with a projected valuation of 6.07 USD Billion by 2024, showcases a robust growth trajectory, particularly within the Product Type segment that includes various pivotal stent categories. The importance of these stents is underscored by their crucial role in enhancing surgical outcomes and improving patient quality of life. Among these, Coronary Stents emerge as a significant player, holding a market value of 2.5 USD Billion in 2024 and expected to expand to 4.2 USD Billion by 2035, thereby dominating the segment due to the rising prevalence of coronary artery diseases globally.
In parallel, Peripheral Stents, valued at 1.3 USD Billion in 2024 and projected to reach 2.1 USD Billion in 2035, are essential in treating various vascular conditions, thus contributing substantially to the overall growth of the Global Surgical Stents Market revenue.
Biliary Stents, which are expected to grow from 0.6 USD Billion in 2024 to 1.1 USD Billion by 2035, play a critical role in gastroenterology, offering significant relief in cases of bile duct obstructions. Urological Stents, valued at 0.9 USD Billion in 2024 and anticipated to increase to 1.6 USD Billion in 2035, address urinary tract issues and have gained traction due to the growing elderly population and increased incidences of urological conditions.
Additionally, Gastrointestinal Stents, starting at 1.2 USD Billion in 2024 and rising to 1.9 USD Billion by 2035, have become crucial in managing gastrointestinal obstructions, thereby reflecting the demand in surgical procedures aimed at treating complex gastrointestinal diseases. Collectively, these insights from the Global Surgical Stents Market segmentation illustrate the market dynamics, with coronary and peripheral stents leading the charge, driven by advancements in technology and a growing patient base seeking improved healthcare solutions.
The trends in minimally invasive procedures further enhance the market growth, as patients and healthcare providers alike prioritize effective and less invasive treatment options. However, challenges such as the high costs of stent procedures and potential complications can impact market penetration. Nevertheless, the increasing demand for innovative stent technology presents significant opportunities for market participants to expand their product offerings and cater to the evolving needs of patients and healthcare systems worldwide. Overall, the Global Surgical Stents Market data indicates a steady upward trajectory, with distinct segments showcasing varied growth patterns that reflect both ongoing technological improvements and the broader healthcare landscape.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Surgical Stents Market Material Insights
The Global Surgical Stents Market, focusing on the Material segment, reveals a diverse landscape critical for the healthcare industry. By 2024, the market is expected to be valued at 6.07 billion USD, showcasing the significant demand for advanced stent solutions. Among the various materials, Metal Stents are prevalent due to their durability and effectiveness in vascular applications, while Polymer Stents gain traction for their flexibility and lower risk of restenosis. Bioabsorbable Stents present innovative solutions, gradually dissolving in the body and reducing long-term complications.
Coated Stents are also crucial, as their specialized coatings enhance biocompatibility and performance, addressing specific medical needs. This segmentation reflects ongoing trends towards personalized medicine and minimal invasiveness, thereby fostering growth in the Global Surgical Stents Market revenue. With increasing investment in Research and Development and advancements in material science, there are ample opportunities for innovation. However, challenges related to regulatory approvals and patient safety remain. Overall, the Global Surgical Stents Market data highlights an evolving sector driven by technological advancements and changing patient needs.
Surgical Stents Market End User Insights
The Global Surgical Stents Market revenue is projected to reach 6.07 USD billion in 2024, driven by increasing demand across various End User settings. Hospitals are key players in this segment, as they perform a large volume of surgeries requiring stent placements, integrating advanced technologies and procedures. Ambulatory Surgical Centers (ASCs) are gaining traction due to the rising preference for outpatient care, reflecting efficiency and patient convenience. Specialty Clinics, concentrating on specific fields such as cardiology or urology, have become vital for personalized stent applications and education.
The growth of the Global Surgical Stents Market segmentation emphasizes the need for improved surgical outcomes, with advancements in stent design and biocompatibility. The market's growth is further supported by a rise in chronic diseases and an aging population globally, presenting numerous opportunities for innovation and tailored care.
However, challenges such as regulatory hurdles and the high cost of advanced stent technologies may influence market dynamics, necessitating adaptive strategies within the industry. Overall, the collaboration among these varied End Users fosters a comprehensive healthcare approach to enhancing patient care and operational efficiency.
Surgical Stents Market Delivery Method Insights
The Global Surgical Stents Market is experiencing significant growth, projected to reach a valuation of 6.07 billion USD by 2024, increasing to 10.2 billion USD by 2035. This growth can be attributed to advancements in medical technology, increasing incidences of cardiovascular diseases, and the demand for minimally invasive procedures. Within the Delivery Method segment, Balloon-Expandable Stents and Self-Expanding Stents present distinct advantages that cater to a variety of clinical needs. Balloon-Expandable Stents are essential for their precise deployment capability in treatment procedures, while Self-Expanding Stents, with their ability to adapt to the vascular structure, are gaining traction due to their ease of use and flexibility.
The rapid adoption of these methods is significant, as they improve patient outcomes and reduce recovery times. Furthermore, the Global Surgical Stents Market data showcases that the demand for effective and reliable stenting solutions continues to rise, driven by a growing aging population and increasing awareness of cardiac health. Continuous Research and Development efforts are also key to enhancing these stent technologies, fueling the market growth further.
Surgical Stents Market Regional Insights
The Global Surgical Stents Market revenue is expected to show significant growth on a regional basis, with North America holding the majority share, valued at 2.45 USD Billion in 2024 and projected to grow to 4.1 USD Billion by 2035. This dominance can be attributed to advanced healthcare infrastructure and high prevalence of chronic diseases requiring stenting procedures. Europe follows closely, with a valuation of 1.8 USD Billion in 2024, rising to 2.8 USD Billion by 2035, benefiting from strong regulatory frameworks and technological advancements in medical devices.
The APAC region is also becoming increasingly important, starting at 1.5 USD Billion in 2024 and reaching 2.6 USD Billion by 2035, driven by expanding healthcare access and growing population demographics.
South America and the MEA regions represent smaller segments, valued at 0.7 USD Billion and 0.62 USD Billion respectively in 2024. However, they are gradually progressing, particularly in urban centers, where healthcare investments are rising, indicating potential opportunities for market players. Overall, the Global Surgical Stents Market data reveals regional dynamics influenced by healthcare expenditures, population health needs, and technological innovation promoting market growth across these regions.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Surgical Stents Market Key Players and Competitive Insights
The Global Surgical Stents Market is characterized by intense competition driven by the increasing prevalence of chronic diseases, a rising aging population, and rapid technological advancements in medical devices. Various companies are striving to enhance their product offerings while ensuring compliance with regulatory standards and addressing the diverse needs of healthcare providers and patients worldwide. Market entrants are focusing on the development of innovative stent designs and materials, as well as improving biocompatibility and patient outcomes. Companies are also investing significantly in research and development, aiming to capture a larger share of this lucrative market.
In addition, strategic collaborations, partnerships, and mergers and acquisitions are commonplace as firms seek to bolster their market position and expand their geographical footprint.Endo International has established itself as a formidable player within the Global Surgical Stents Market by leveraging its robust research and development capabilities. The company is recognized for its focus on enhancing the efficacy and reliability of its stents, which include a range of designs tailored for specific medical conditions.
Endo International's strengths lie in its extensive experience in the medical device sector and its commitment to innovation. The company prioritizes patient safety and outcomes, leading to the development of technologies that resonate with healthcare professionals and patients alike. Endo International has successfully positioned itself in several regions globally, utilizing its network of production and distribution facilities aimed at meeting the growing demand for surgical stents while maintaining high-quality standards.
Abbott Laboratories is another key contender in the Global Surgical Stents Market, offering an array of products designed to address various surgical needs, including coronary, vascular, and urology stenting solutions. The company is noted for its state-of-the-art stent technologies that incorporate advanced materials and delivery systems, which have significantly improved clinical outcomes and patient safety.
Abbott Laboratories has a strong market presence, bolstered by its comprehensive portfolio of cardiac and vascular intervention products. The company's emphasis on innovation is evident in its commitment to R&D and partnerships with leading healthcare institutions, facilitating advances that enhance stent performance. Abbott Laboratories has also engaged in strategic mergers and acquisitions to bolster its position in the market, thereby expanding its capabilities and streamlining its operations to meet the evolving demands of the global healthcare landscape.
Key Companies in the Surgical Stents Market Include
- Endo International
- Abbott Laboratories
- Jiangsu Sina Medical
- Cook Medical
- Zhejiang Nuanxin Medical
- Johnson and Johnson
- B. Braun Melsungen
- Terumo Corporation
- W. L. Gore and Associates
- MicroPort Scientific
- Medtronic
- Cousin Biotech
- Stryker Corporation
- Cardinal Health
- Boston Scientific
Surgical Stents Market Industry Developments
Recent developments in the Global Surgical Stents Market have been significant, with a notable focus on technological advancements and regulatory updates. Companies like Abbott Laboratories, Boston Scientific, and Medtronic have been actively enhancing their product lines with innovative features to improve patient outcomes.
Current affairs indicate that there has been an increasing investment in research and development to manufacture stents with biocompatible materials and technologies to reduce the risk of thrombosis. In terms of mergers and acquisitions, there have been recent moves such as Johnson and Johnson acquiring an emerging technology company to broaden their portfolio, and in August 2023, Cook Medical announced its merger with a regional player to enhance distribution capabilities in Asia Pacific.
Market valuations have also shown notable growth, driven by an aging population and rising prevalence of cardiovascular diseases globally. Over the past two to three years, significant market shifts have occurred, including the introduction of biodegradable stents and enhanced delivery systems, impacting competitive dynamics and driving companies to adapt their strategies. Overall, the surgical stents market continues to evolve, reflecting both challenges and opportunities in an increasingly sophisticated healthcare landscape.
Surgical Stents Market Segmentation Insights
Surgical Stents Market Product Type Outlook
- Coronary Stents
- Peripheral Stents
- Biliary Stents
- Urological Stents
- Gastrointestinal Stents
Surgical Stents Market Material Outlook
- Metal Stents
- Polymer Stents
- Bioabsorbable Stents
- Coated Stents
Surgical Stents Market End User Outlook
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
Surgical Stents Market Delivery Method Outlook
- Balloon-Expandable Stents
- Self-Expanding Stents
Surgical Stents Market Regional Outlook
- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa
| Report Attribute/Metric Source: |
Details |
| MARKET SIZE 2023 |
5.79(USD Billion) |
| MARKET SIZE 2024 |
6.07(USD Billion) |
| MARKET SIZE 2035 |
10.2(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) |
4.82% (2025 - 2035) |
| REPORT COVERAGE |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR |
2024 |
| MARKET FORECAST PERIOD |
2025 - 2035 |
| HISTORICAL DATA |
2019 - 2024 |
| MARKET FORECAST UNITS |
USD Billion |
| KEY COMPANIES PROFILED |
Endo International, Abbott Laboratories, Jiangsu Sina Medical, Cook Medical, Zhejiang Nuanxin Medical, Johnson and Johnson, B. Braun Melsungen, Terumo Corporation, W. L. Gore and Associates, MicroPort Scientific, Medtronic, Cousin Biotech, Stryker Corporation, Cardinal Health, Boston Scientific |
| SEGMENTS COVERED |
Product Type, Material, End User, Delivery Method, Regional |
| KEY MARKET OPPORTUNITIES |
Rising prevalence of chronic diseases, Technological advancements in stent design, Growth in minimally invasive surgeries, Increasing geriatric population, Expanding healthcare infrastructure in emerging markets |
| KEY MARKET DYNAMICS |
Technological advancements in stents, Increasing prevalence of cardiovascular diseases, Rising geriatric population, Growing demand for minimally invasive surgeries, Favorable reimbursement policies |
| COUNTRIES COVERED |
North America, Europe, APAC, South America, MEA |
Surgical Stents Market Highlights:
Frequently Asked Questions (FAQ) :
The Global Surgical Stents Market is expected to be valued at 6.07 USD Billion in 2024.
By 2035, the Global Surgical Stents Market is projected to reach a value of 10.2 USD Billion.
The expected CAGR for the Global Surgical Stents Market from 2025 to 2035 is 4.82%.
In 2024, North America holds the largest market share in the Global Surgical Stents Market, valued at 2.45 USD Billion.
The market value of Coronary Stents in 2024 is estimated to be 2.5 USD Billion.
Key players in the Global Surgical Stents Market include Endo International, Abbott Laboratories, Johnson and Johnson, and Medtronic.
The market size of Peripheral Stents is projected to be 2.1 USD Billion in 2035.
By 2035, the Global Surgical Stents Market is expected to see North America at 4.1 USD Billion, Europe at 2.8 USD Billion, and APAC at 2.6 USD Billion.
The expected market value of Urological Stents in 2024 is 0.9 USD Billion.
Anticipated growth opportunities in the Surgical Stents Market include advancements in technology and increasing healthcare accessibility.
